Arno Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2012 | 0 | -14.38M | |
|---|---|---|---|
| 2013 | 0 | -58.22M | |
| 2014 | 0 | 7.77M | |
| 2015 | 0 | -11.53M | |
| 2019 | 0 | 0 | |
| 2020 | 0 | 0 | |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
ARNI Income Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 7.62K | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | -7.62K | 0 | 0 | 0 |
Operating exp. | ||||||||
Research and development | 0 | 0 | 0 | 0 | 8.65M | 14.84M | 13.47M | 8.53M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 0 | 0 | 0 | 13.41M | 21.49M | 16.94M | 10.83M |
Operating income | 0 | 0 | 0 | 0 | -13.41M | -21.49M | -16.94M | -10.83M |
Other income (expenses), net | 0 | 0 | 0 | 0 | 1.90M | 29.26M | -22.71M | -3.55M |
Income before tax | 0 | 0 | 0 | 0 | -11.50M | 7.77M | -39.65M | -14.38M |
Income tax expense | 0 | 0 | 0 | 0 | 28.40K | 143 | 18.56M | 0 |
Net income | 0 | 0 | 0 | 0 | -11.53M | 7.77M | -58.22M | -14.38M |
Earnings per share | ||||||||
Basic EPS | 0 | 0 | 0 | 0 | -0.57 | 0.38 | -7.75 | -3.2 |
Diluted EPS | 0 | 0 | 0 | 0 | -0.57 | 0.31 | -7.75 | -3.2 |